We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Exendin (9-39) is a competitive GLP-1 (glucagon-like peptide 1) receptor antagonist. Exendin (9-39) blocks the stimulatory action of GLP-1 amide, exendin-3 and exendin-4 on cAMP production in pancreatic acini. In addition, exendin (9-39) was showed not to interfer the insulin normal secretion.
CAT No:10-101-83
CAS No:133514-43-9 (net)
Synonyms/Alias:Ex4 peptide; Exendin9-39
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C149H234N40O47S |
M.W/Mr. | 3369.8 |
Sequence | H-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 acetate salt |
Application | Exendin (9-39) is a GLP-1 (glucagon-like peptide-1) receptor antagonist and a competitive inhibitor of exendin-3 and exendin-4. |
Areas of Interest | Diabetes |
Source# | Synthetic |
Solubility | −20°C |
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Cationic cell-penetrating peptides are potent furin inhibitors
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com